Company / CapEx per Share
RIGEL PHARMACEUTICALS INC CapEx per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2022
5-year range
$0.00 / $0.00
FY2018-FY2022
Trend
-29.2%
vs FY2021
Sector context
#157 of 192
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's capex per share of $0.00 is lower than 82% of companies in the Health Care sector (FY2022). CapEx per Share has declined for 3 consecutive years, from $0.01 in FY2019 to $0.00 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2022 with a 5-year CAGR of +15.1%.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -33.0%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 192This company $0.00 Sector average $2.46
▼
-99.9% below sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's capex per share has declined for 3 consecutive years.
- In FY2022, capex per share decreased 29.2% year-over-year.
- Ranks #157 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -29.2% |
| FY2021 | $0.00 | -50.7% |
| FY2020 | $0.01 | -13.7% |
| FY2019 | $0.01 | +58.9% |
| FY2018 | $0.01 | +321.8% |
| FY2017 | $0.00 | -84.8% |
| FY2016 | $0.01 | +38.0% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026